ArticleAnnals of medicine and surgery (2012)2023
Two years of COVID-19 vaccination in Nigeria: a review of the current situation of the pandemic: a literature review.
Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Precision immunisation: reaching zero-dose children in underserved communities in Niger State, Nigeria.BMJ global health · 2026Article
- Evaluating a Behavioral Insights-Informed Social Media Campaign to Increase HPV Vaccination During Routine Immunization in Nigeria.Vaccines · 2026Article
- Impact of behavioral insights-informed social media campaigns on HPV vaccination in Bangladesh.PLOS global public health · 2026Article
- Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence.Health science reports · 2025Article
- Knowledge, perceptions and acceptance of COVID-19 Vaccine in Plateau States, Nigeria: A Qualitative Study.medRxiv : the preprint server for health sciences · 2025Article
- Negotiating cohabitation in a Nigerian abattoir: One Health perspectives of human-animal-ecosystem interactions examined in the light of the SARS-CoV-2 pandemic.One health outlook · 2025Article
- Health workers' perception of digital technology use to improve mental health services.Journal of public health in Africa · 2025Article
- Factors shaping Covid-19 vaccine acceptability among young people in South Africa and Nigeria: An exploratory qualitative study.PLOS global public health · 2025Article
- Current State and Challenges of Local Production of Vaccines in Nigeria.Public health challenges · 2024Article
- Provider and community perceptions of integrated COVID-19 and routine childhood immunisation programmes in Nigeria: a qualitative exploratory study.BMC health services research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curtailing COVID-19 outbreaks has been the major focus for many countries following the onset of the COVID-19 pandemic. Nigeria expanded its effort with the commencement of its vaccination program against COVID-19 in March 2021 after several less effective interventions as vaccine introduction was implemented. Following the introduction of the vaccines, Nigeria is expected to meet the worldwide COVID-19 eradication target of vaccinating 40% and 70% of the population, respectively, by the end of 2021 and 2022. Nigeria was unable to meet the target at the commencement of the program. The low vaccination rate, attributed to a low acceptance rate of vaccines, a lack of access to vaccines, poor communication, a weak cold-chain system, and inadequate infrastructure in the country, resulted in the complete vaccination of only 15% of the Nigerian populace as of 21 September 2022. To improve the vaccination rate, the COVID-19 Crisis Communication Centre was launched. Also, the implementation of delivery of service, logistics, accountability, supportive supervision, communication, and electronic management of immunization data scaled the vaccination rate to more than 54% of the target populace as of December 2022. Since the introduction of the COVID-19 vaccine, a substantial change in the prevalence and mortality rate has been perceived owing to the country's progress toward achieving herd immunity against COVID-19. The country ascertained the percentage of cumulative deaths before the vaccination process to be 60.4%, which was reduced to 39.6% post-vaccination. In comparison, the percentage of confirmed COVID-19 cases was reduced from 58.3 to 41.7% post-vaccination. The authors recommend that the government and relevant public health authorities ensure meticulous documentation of the outcomes resulting from vaccination initiatives and facilitate the accessibility of this information to the general public to boost the vaccination rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.